1. Home
  2. EVC vs ACHV Comparison

EVC vs ACHV Comparison

Compare EVC & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$9.66

Market Cap

335.0M

Sector

Industrials

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.69

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
ACHV
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
172.0M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
EVC
ACHV
Price
$9.66
$4.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.67
AVG Volume (30 Days)
4.0M
1.2M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
5.35%
N/A
EPS Growth
47.59
N/A
EPS
0.13
N/A
Revenue
$536,034,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$73.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$2.00
52 Week High
$9.60
$6.15

Technical Indicators

Market Signals
Indicator
EVC
ACHV
Relative Strength Index (RSI) 76.24 50.17
Support Level $2.66 $4.65
Resistance Level N/A $4.98
Average True Range (ATR) 1.01 0.42
MACD 0.17 -0.11
Stochastic Oscillator 92.64 20.16

Price Performance

Historical Comparison
EVC
ACHV

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: